SCHEMBL21388539

SCHEMBL21388539

CC(C)c1n[nH]c(=O)c2c1COC(n1nc(C(C)C)c3c(c1=O)COCC3)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19131102 0.78 PARP1 (0.35) —
SCHEMBL18237564 0.78 PARP1 (0.35) —
SCHEMBL19153378 0.76 — —
SCHEMBL17229743 0.64 HCAR2 (0.33) —
SCHEMBL17229777 0.63 HCAR2 (0.35) —
SCHEMBL19902540 0.62 PARP1 (0.51) —
SCHEMBL19902539 0.62 PARP1 (0.48) —
SCHEMBL17705711 0.62 IDH1 (0.33) —
SCHEMBL20033633 0.61 — —
SCHEMBL19152895 0.60 WNT3A (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190290771-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO, INC. 2019-09-26 — — US disclosed
Send feedback